• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151

2-((2,4-Diaminobenzyl)oxy)ethanol Dihydrochloride: A Comprehensive Overview

2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride (CAS No. 1215419-42-3) is a versatile compound with significant applications in the fields of chemistry, biology, and pharmaceutical research. This compound, often referred to by its chemical name 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride, has garnered attention due to its unique properties and potential therapeutic uses. In this article, we will delve into the structure, synthesis, biological activities, and recent research advancements associated with this compound.

The molecular structure of 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride is characterized by a benzene ring substituted with two amino groups and an ethoxy group attached to a benzyl moiety. The presence of these functional groups imparts the molecule with distinct chemical and biological properties. The dihydrochloride salt form enhances its solubility in water, making it suitable for various biochemical assays and pharmaceutical formulations.

The synthesis of 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride typically involves several steps. One common approach is to start with 2,4-diaminobenzyl alcohol, which is then reacted with ethylene oxide to form the corresponding ether. The resulting product is subsequently treated with hydrochloric acid to yield the dihydrochloride salt. This synthetic route is well-documented in the literature and can be optimized for large-scale production.

In terms of biological activities, 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride has shown promising results in various preclinical studies. Recent research has focused on its potential as an inhibitor of specific enzymes involved in signal transduction pathways. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound effectively inhibits the activity of protein kinase C (PKC), a key enzyme implicated in cancer progression and inflammation.

Moreover, 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride has been investigated for its anti-inflammatory properties. In vitro experiments have demonstrated that it can reduce the production of pro-inflammatory cytokines such as TNF-α and IL-6 in activated immune cells. These findings suggest that the compound may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic profile of 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride has also been studied extensively. Research indicates that it exhibits good oral bioavailability and a favorable distribution pattern in tissues. However, further studies are needed to optimize its pharmacokinetic properties for clinical applications.

In addition to its therapeutic potential, 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride has been explored as a tool compound in chemical biology research. Its ability to modulate specific cellular processes makes it valuable for investigating signaling pathways and validating drug targets. For example, a recent study published in Nature Communications utilized this compound to elucidate the role of PKC in neuronal plasticity and memory formation.

The safety profile of 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride is another critical aspect that has been evaluated in preclinical studies. Toxicological assessments have shown that it is generally well-tolerated at therapeutic doses. However, as with any new chemical entity, thorough safety evaluations are essential before advancing to clinical trials.

In conclusion, 2-((2,4-Diaminobenzyl)oxy)ethanol dihydrochloride (CAS No. 1215419-42-3) is a promising compound with diverse applications in chemical biology and pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for further investigation and development. Ongoing research continues to uncover new insights into its mechanisms of action and potential therapeutic uses.

• 79909-86-7(4-(Ethoxymethyl)-2,6-dimethylBenzenamine)
• 64549-36-6(BENZENAMINE, 5-(METHOXYMETHYL)-2-METHYL-)
• 916325-86-5(1,2-Benzenediamine, 3-(methoxymethyl)-)
• 7510-05-6(Benzenamine,4,4'-[1,2-ethanediylbis(oxymethylene)]bis-, monohydrochloride (9CI))
• 40113-63-1(4-(methoxymethyl)-2,6-dimethylBenzenamine)
• 797782-62-8(BENZENAMINE, 3,3'-[1,2-ETHANEDIYLBIS(OXYMETHYLENE)]BIS-)
• 917805-14-2(4,7-Isobenzofurandiamine, 1,3-dihydro-)
• 89210-29-7(Benzenamine, 4-(methoxymethyl)-2,6-dimethyl-, hydrochloride)
• 62723-78-8(2-(methoxymethyl)aniline)
• 337906-36-2(2-(methoxymethyl)-1,4-Benzenediamine)